Demonstrating GMP Readiness And Understanding Common Pain Points

In this segment from the Bioprocess Online Live event, “Making The Jump To GMP: Material Decisions For Clinical Manufacturing,” panelists discuss the most common challenges in scaling and transitioning a process into GMP manufacturing. They identify things such as supplier or CDMO constraints, facility fit, and technology transfers as some of the more prevalent challenges in this transition. Panelist Mary Rodley, an independent consultant at Medius Consulting, stresses the importance of risk assessments and advises developers on when they should be instituted.